• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体腺瘤患者拒绝手术治疗:一项基于人群的分析。

Refusal of Surgery in Pituitary Adenoma Patients: A Population-Based Analysis.

作者信息

Birkenbeuel Jack L, Lehrich Brandon M, Goshtasbi Khodayar, Abiri Arash, Hsu Frank P K, Kuan Edward C

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, CA 92868, USA.

Medical Scientist Training Program, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.

出版信息

Cancers (Basel). 2022 Oct 30;14(21):5348. doi: 10.3390/cancers14215348.

DOI:10.3390/cancers14215348
PMID:36358767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9656152/
Abstract

We characterized the clinical and sociodemographic factors predictive of surgery refusal in pituitary adenoma (PA) patients. We queried the National Cancer Database (NCDB) to identify adult PA patients treated from 2004−2015 receiving or refusing surgery. Multivariate logistic regression and Cox proportional-hazards analysis identified clinical and/or sociodemographic factors predictive of surgery refusal or mortality, respectively. Of the 34,226 patients identified, 280 (0.8%) refused surgery. On multivariate logistic regression, age > 65 (OR: 2.64; p < 0.001), African American race (OR: 1.70; p < 0.001), Charlson-Deyo Comorbidity (C/D) Index > 2 (OR: 1.52; p = 0.047), and government insurance (OR: 2.03; p < 0.001) or being uninsured (OR: 2.16; p = 0.03) were all significantly associated with surgery refusal. On multivariate cox-proportional hazard analysis, age > 65 (HR: 2.66; p < 0.001), tumor size > 2 cm (HR: 1.30; p < 0.001), C/D index > 1 (HR: 1.53; p < 0.001), having government insurance (HR: 1.66; p < 0.001) or being uninsured (HR: 1.67; p < 0.001), and surgery refusal (HR: 2.28; p < 0.001) were all significant predictors of increased mortality. Macroadenoma patients receiving surgery had a significant increase in overall survival (OS) compared to those who refused surgery (p < 0.001). There are significant sociodemographic factors that influence surgery refusal in PA patients. An individualized approach is warranted that considers functional status, clinical presentations, and patient choice.

摘要

我们对垂体腺瘤(PA)患者中预测手术拒绝的临床和社会人口统计学因素进行了特征分析。我们查询了国家癌症数据库(NCDB),以识别2004 - 2015年期间接受或拒绝手术治疗的成年PA患者。多变量逻辑回归和Cox比例风险分析分别确定了预测手术拒绝或死亡的临床和/或社会人口统计学因素。在识别出的34226例患者中,280例(0.8%)拒绝手术。多变量逻辑回归分析显示,年龄>65岁(比值比:2.64;p<0.001)、非裔美国人种族(比值比:1.70;p<0.001)、Charlson - Deyo合并症(C/D)指数>2(比值比:1.52;p = 0.047)以及政府保险(比值比:2.03;p<0.001)或未参保(比值比:2.16;p = 0.03)均与手术拒绝显著相关。多变量Cox比例风险分析显示,年龄>65岁(风险比:2.66;p<0.001)、肿瘤大小>2 cm(风险比:1.30;p<0.001)、C/D指数>1(风险比:1.53;p<0.001)、拥有政府保险(风险比:1.66;p<0.001)或未参保(风险比:1.67;p<0.001)以及手术拒绝(风险比:2.28;p<0.001)均是死亡率增加的显著预测因素。与拒绝手术的患者相比,接受手术的大腺瘤患者总生存期(OS)显著延长(p<0.001)。存在影响PA患者手术拒绝的显著社会人口统计学因素。有必要采取个性化方法,综合考虑功能状态、临床表现和患者选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7608/9656152/5f38ad2f1757/cancers-14-05348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7608/9656152/5f38ad2f1757/cancers-14-05348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7608/9656152/5f38ad2f1757/cancers-14-05348-g001.jpg

相似文献

1
Refusal of Surgery in Pituitary Adenoma Patients: A Population-Based Analysis.垂体腺瘤患者拒绝手术治疗:一项基于人群的分析。
Cancers (Basel). 2022 Oct 30;14(21):5348. doi: 10.3390/cancers14215348.
2
Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database.利用国家癌症数据库分析直肠癌患者拒绝手术的相关因素及其对生存的影响。
J Gastrointest Oncol. 2021 Aug;12(4):1482-1497. doi: 10.21037/jgo-20-437.
3
Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer.肌层浸润性膀胱癌患者拒绝根治性膀胱切除术的相关因素。
Urol Oncol. 2021 Apr;39(4):236.e9-236.e20. doi: 10.1016/j.urolonc.2020.11.023. Epub 2021 Jan 8.
4
Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study.种族与早期胰腺癌患者拒绝手术治疗的健康差异:NCDB 队列研究。
Ann Surg Oncol. 2018 Nov;25(12):3427-3435. doi: 10.1245/s10434-018-6680-6. Epub 2018 Jul 24.
5
A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.鼻咽癌治疗管理与生存结局的综合分析
Otolaryngol Head Neck Surg. 2021 Jul;165(1):93-103. doi: 10.1177/0194599820973241. Epub 2020 Nov 24.
6
Characteristics and overall survival in pediatric versus adult pituitary adenoma: a National Cancer Database analysis.儿童与成人垂体腺瘤的特征和总生存:国家癌症数据库分析。
Pituitary. 2021 Oct;24(5):714-723. doi: 10.1007/s11102-021-01146-3. Epub 2021 Apr 30.
7
Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.社会人口统计学因素预测 I-III 期结肠癌患者的手术拒绝率。
J Surg Oncol. 2020 Jun;121(8):1306-1313. doi: 10.1002/jso.25917. Epub 2020 Mar 29.
8
Correlates of Refusal of Surgery in the Treatment of Non-metastatic Pancreatic Adenocarcinoma.非转移性胰腺导管腺癌患者拒绝手术治疗的相关因素。
Ann Surg Oncol. 2019 Jan;26(1):98-108. doi: 10.1245/s10434-018-6708-y. Epub 2018 Aug 25.
9
Refusal of surgery for colon cancer: Sociodemographic disparities and survival implications among US patients with resectable disease.拒绝结肠癌手术:美国可切除疾病患者的社会人口统计学差异和生存意义。
Am J Surg. 2021 Jan;221(1):39-45. doi: 10.1016/j.amjsurg.2020.06.020. Epub 2020 Jun 23.
10
Surgery Refusal Among Black and Hispanic Women with Non-Metastatic Breast Cancer.非转移性乳腺癌的黑人和西班牙裔女性的手术拒绝。
Ann Surg Oncol. 2022 Oct;29(11):6634-6643. doi: 10.1245/s10434-022-11832-6. Epub 2022 May 5.

引用本文的文献

1
Navigating Choices: Determinants and Outcomes of Surgery Refusal in Thyroid Cancer Patients Using SEER Data.选择的导航:利用监测、流行病学与结果(SEER)数据探究甲状腺癌患者拒绝手术的决定因素及后果
Cancers (Basel). 2023 Jul 20;15(14):3699. doi: 10.3390/cancers15143699.

本文引用的文献

1
Refusal of cancer-directed treatment by colon cancer patients: Risk factors and survival outcomes.结肠癌患者拒绝癌症定向治疗:危险因素和生存结果。
Am J Surg. 2020 Dec;220(6):1605-1612. doi: 10.1016/j.amjsurg.2020.04.022. Epub 2020 Apr 26.
2
The impact of surgery refusal on thyroid cancer survival: a SEER-based analysis.手术拒绝对甲状腺癌生存率的影响:基于监测、流行病学和最终结果(SEER)数据库的分析
Endocrine. 2020 Nov;70(2):356-363. doi: 10.1007/s12020-020-02301-9. Epub 2020 Apr 19.
3
Endoscopic versus nonendoscopic surgery for resection of pituitary adenomas: a national database study.
内镜手术与非内镜手术治疗垂体腺瘤:全国数据库研究。
J Neurosurg. 2020 Mar 13;134(3):816-824. doi: 10.3171/2020.1.JNS193062. Print 2021 Mar 1.
4
Treatment of stage I-III rectal cancer: Who is refusing surgery?治疗 I-III 期直肠癌:谁在拒绝手术?
J Surg Oncol. 2020 May;121(6):990-1000. doi: 10.1002/jso.25873. Epub 2020 Feb 23.
5
The Role of Surgery in the Management of Prolactinomas.《泌乳素瘤的外科治疗作用》
Neurosurg Clin N Am. 2019 Oct;30(4):509-514. doi: 10.1016/j.nec.2019.05.010. Epub 2019 Jul 2.
6
Visual and Endocrine Recovery Following Conservative and Surgical Treatment of Pituitary Apoplexy: A Meta-Analysis.保守治疗与手术治疗垂体卒中后视觉和内分泌功能的恢复:一项荟萃分析。
World Neurosurg. 2019 Dec;132:33-40. doi: 10.1016/j.wneu.2019.08.115. Epub 2019 Aug 27.
7
Functioning Pituitary Adenomas - Current Treatment Options and Emerging Medical Therapies.功能性垂体腺瘤——当前的治疗选择与新兴药物疗法
Eur Endocrinol. 2019 Apr;15(1):30-40. doi: 10.17925/EE.2019.15.1.30. Epub 2019 Apr 12.
8
Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management.无功能性垂体腺瘤:垂体手术的适应证和术后处理。
Pituitary. 2019 Aug;22(4):422-434. doi: 10.1007/s11102-019-00960-0.
9
Refusal of Cancer-Directed Surgery in Head and Neck Squamous Cell Carcinoma Patients.头颈部鳞状细胞癌患者拒绝针对癌症的手术治疗
Laryngoscope. 2019 Jun;129(6):1368-1373. doi: 10.1002/lary.27116. Epub 2018 Aug 2.
10
Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center.与显微镜下和内镜下经蝶窦垂体手术相关的并发症:在一家三级垂体专科中心连续治疗的1153例病例的经验。
J Neurosurg. 2018 Jun 1;130(5):1576-1583. doi: 10.3171/2017.12.JNS172318. Print 2019 May 1.